Hui Chen1, Lei Qian2, Qiangsheng Lv3, Jianxiu Yu2, Wei Wu4, Haixin Qian4. 1. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Soochow UniversitySuzhou 215006, Jiangsu Province, China; Department of General Surgery, The People's Hospital of Binhai CountyBinhai 224500, Jiangsu Province, China. 2. Department of Laboratory Medicine, The People's Hospital of Binhai County Binhai 224500, Jiangsu Province, China. 3. Department of General Surgery, The People's Hospital of Binhai County Binhai 224500, Jiangsu Province, China. 4. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Soochow University Suzhou 215006, Jiangsu Province, China.
Abstract
Objectives: Persistent low-grade chronic inflammation is common in type 2 diabetes (T2D) and obesity. To date, the underlying molecular mechanism is not well understood. In this study, we aimed to investigate gut microbiota and the expression of monocyte surface molecules in obese T2D subjects who underwent Roux-en-Y gastric bypass (RYGB) surgery. Methods: Twenty-four T2D patients were enrolled. Gut microbiota was assessed by measuring bacterial DNA. The phenotypes and biological functions of monocytes, and the expression of monocyte surface molecules were examined by flow cytometry. Results: RYGB led to significant alterations in the phenotypes of monocytes. Moreover, the ability of monocyte migration was significantly decreased after RYGB (P<0.05), which was consistent with reduced Chemokine-receptors CCR2 expression of CD14+CD16+ monocytes (P<0.05) and CX3CR1 expression of the three monocytes subsets (P<0.05). RYGB also resulted in a shift of gut microbiota in the obese T2D patients. Spearman's rank correlation coefficient showed a link between gut microbiota and monocyte subsets where the increased Bacteroidetes was negatively correlated with the variation of CD14dimCD16+ monocyte percentage (r=-0.477, P<0.05). Furthermore, the decreased counts of Escherichia were positively correlated with the variation of TNF-α secretion (r=0.442, P<0.05) and TLR4 (r=0.425, P<0.05) expression onCD14+CD16+ monocytes. Conclusions: This study, for the first time, demonstrated a link between the changes in gut microbiota and alterations in both phenotypes and functions of monocytes after RYGB, which may contribute significantly to the low-grade chronic inflammation in obese T2D patients.
Objectives: Persistent low-grade chronic inflammation is common in type 2 diabetes (T2D) and obesity. To date, the underlying molecular mechanism is not well understood. In this study, we aimed to investigate gut microbiota and the expression of monocyte surface molecules in obese T2D subjects who underwent Roux-en-Y gastric bypass (RYGB) surgery. Methods: Twenty-four T2D patients were enrolled. Gut microbiota was assessed by measuring bacterial DNA. The phenotypes and biological functions of monocytes, and the expression of monocyte surface molecules were examined by flow cytometry. Results: RYGB led to significant alterations in the phenotypes of monocytes. Moreover, the ability of monocyte migration was significantly decreased after RYGB (P<0.05), which was consistent with reduced Chemokine-receptors CCR2 expression of CD14+CD16+ monocytes (P<0.05) and CX3CR1 expression of the three monocytes subsets (P<0.05). RYGB also resulted in a shift of gut microbiota in the obese T2D patients. Spearman's rank correlation coefficient showed a link between gut microbiota and monocyte subsets where the increased Bacteroidetes was negatively correlated with the variation of CD14dimCD16+ monocyte percentage (r=-0.477, P<0.05). Furthermore, the decreased counts of Escherichia were positively correlated with the variation of TNF-α secretion (r=0.442, P<0.05) and TLR4 (r=0.425, P<0.05) expression onCD14+CD16+ monocytes. Conclusions: This study, for the first time, demonstrated a link between the changes in gut microbiota and alterations in both phenotypes and functions of monocytes after RYGB, which may contribute significantly to the low-grade chronic inflammation in obese T2D patients.
Entities:
Keywords:
Gut microbiota; chronic inflammation; cytokine; monocytes subsets; type 2 diabetes
Authors: Kyrill S Rogacev; Christof Ulrich; Lutz Blömer; Florian Hornof; Katrin Oster; Maren Ziegelin; Bodo Cremers; Yvonne Grenner; Jürgen Geisel; Axel Schlitt; Hans Köhler; Danilo Fliser; Matthias Girndt; Gunnar H Heine Journal: Eur Heart J Date: 2009-08-17 Impact factor: 29.983
Authors: P Krinninger; R Ensenauer; K Ehlers; K Rauh; J Stoll; S Krauss-Etschmann; H Hauner; H Laumen Journal: J Clin Endocrinol Metab Date: 2014-02-25 Impact factor: 5.958
Authors: Scott V Monte; Joseph A Caruana; Husam Ghanim; Chang Ling Sia; Kelly Korzeniewski; Jerome J Schentag; Paresh Dandona Journal: Surgery Date: 2011-11-16 Impact factor: 3.982
Authors: Christian Herder; Kristine Færch; Maren Carstensen-Kirberg; Gordon D Lowe; Rita Haapakoski; Daniel R Witte; Eric J Brunner; Michael Roden; Adam G Tabák; Mika Kivimäki; Dorte Vistisen Journal: Eur J Endocrinol Date: 2016-08-04 Impact factor: 6.664
Authors: Farnaz Fouladi; Ian M Carroll; Thomas J Sharpton; Emily Bulik-Sullivan; Leslie Heinberg; Kristine J Steffen; Anthony A Fodor Journal: Gut Microbes Date: 2021 Jan-Dec
Authors: Dimitrios A Koutoukidis; Susan A Jebb; Matthew Zimmerman; Afolarin Otunla; J Aaron Henry; Anne Ferrey; Ella Schofield; Jade Kinton; Paul Aveyard; Julian R Marchesi Journal: Gut Microbes Date: 2022 Jan-Dec